Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
October 21 at 11:45 am PDT/2:45 pm EDT
This session will open with a conversation with Stephen Hahn, Commissioner, US Food and Drug Administration, followed by a panel discussion.
The current pandemic has increased the challenges faced by patients involved in the healthcare system, highlighting health disparities and preventing those who are free of COVID-19 from feeling safe in seeking care. Technology offers opportunities for patients to connect with the healthcare system in a new way, allowing access to providers through telehealth and providing tools for patients to obtain information and receive necessary medications. This panel will discuss opportunities offered through health innovations to benefit patients, address health inequity, and improve health in the United States.
Part 1:
-
Guest Stephen Hahn, Commissioner, US Food and Drug Administration
-
Moderator Esther Krofah, Executive Director, FasterCures, Milken Institute
Part 2:
-
Moderator Damian Garde, National Biotech Reporter, STAT
-
Speaker Megan Callahan, Vice President, Healthcare, Lyft
-
Speaker Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, Pfizer
-
Speaker Meena Seshamani, Vice President, Clinical Care Transformation, MedStar Health
Guest
Stephen Hahn
Commissioner, US Food and Drug Administration
Speakers
Angela Hwang
Group President, Pfizer Biopharmaceuticals Group, Pfizer
Meena Seshamani
Vice President, Clinical Care Transformation, MedStar Health
Megan Callahan
Vice President, Healthcare, Lyft
Moderators
Damian Garde
National Biotech Reporter, STAT
Esther Krofah
Executive Director, FasterCures, Milken Institute